Motus GI to Release First Quarter Results and Provide a Business Update on May 12
Motus GI Holdings (NASDAQ: MOTS) will release its first-quarter financial results on May 12, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Motus GI Holdings (NASDAQ: MOTS) will release its first-quarter financial results on May 12, 2022, after market close. A conference call for discussion of results and recent corporate updates will follow at 4:30 p.m. ET. The event will be accessible via a webcast, with a replay available on the company’s website for 90 days. Motus GI specializes in endoscopy solutions aimed at enhancing clinical outcomes and cost-efficiency in gastrointestinal diagnosis and management.
Positive
- Scheduled first-quarter financial results release on May 12, 2022.
- Management will discuss results and corporate updates in a conference call.
Negative
- None.
Details
News Market Reaction – MOTS
The recorded move for MOTS in the trading session of this news was -0.60%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FORT LAUDERDALE, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its first quarter financial results on Thursday, May 12, 2022, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.
| Conference Call and Webcast | ||
| Date and Time: | Thursday, May 12, 2022 at 4:30 p.m. ET | |
| Domestic: | 844-825-9789 | |
| International: | 412-317-5180 | |
| Passcode: | 10166381 | |
| Webcast: | https://event.choruscall.com/mediaframe/webcast.html?webcastid=yaYf8LWA | |
A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.
About Motus GI
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.
Investor Contact:
Troy Williams
LifeSci Advisors
(518) 221-0106
twilliams@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.